Drug repurposing for targeting fibronectin in treatment of endometriosis and cancers-Reference-Cited by-同舟云学术

Drug repurposing for targeting fibronectin in treatment of endometriosis and cancers

Published:2023-11-10 Issue: Volume: Page:1-17
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Mahdian Soodeh¹,Moini Ashraf²³⁴,Esfandiari Fereshteh⁵,Shahhoseini Maryam¹²⁶

Affiliation:

1. Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

2. Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

3. Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran

4. Department of Obstetrics and Gynecology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

6. Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran

Funder

Iran National Science Foundation

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2280677

Reference42 articles.

1. Irigenin, a novel lead from Western Himalayan chemiome inhibits Fibronectin-Extra Domain A induced metastasis in Lung cancer cells

2. ProTox-II: a webserver for the prediction of toxicity of chemicals

3. Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis

4. GROMACS: A message-passing parallel molecular dynamics implementation

5. Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone ϕ, ψ and Side-Chain χ1 and χ2 Dihedral Angles